Matthew J. Ellis, MB., BChir., Ph.D., FRCP

Faculty

matthew.ellis@bcm.edu

Faculty: Lester and Sue Smith Breast Center - Administrative
Baylor College of Medicine
Houston, TX, US

BCM-Cullen Building (Office): Room: BCMC-335
Houston, TX, 77030
United States

PhD from University of London: 05/1992 - London, United Kingdom; Molecular Biology

Fellowship at Georgetown University Hospital: 06/1994 - Washington, District of Columbia, United States; Medical Oncology

Residency at Royal College of Physicians: 06/1988 - London, United Kingdom; Medicine

VIICTR Publications List

Lab Page

Breast Center

Activating HER2 mutations in HER2 gene amplification negative breast cancer. " Cancer discovery. 2013;3(2):224-37. 2013 ;
Whole-genome analysis informs breast cancer response to aromatase inhibition. " Nature. 2012;486(7403):353-60.. 2012 ;
Connecting genomic alterations to cancer biology with proteomics: the NCI Clinical Proteomic Tumor Analysis Consortium. " Cancer discovery. 2013;3(10):1108-12. 2012 ;
The genomic landscape of breast cancer as a therapeutic roadmap. " Cancer discovery. 2013;3(1):27-34. 2013 ;
New concepts in breast cancer genomics and genetics.. " Breast cancer research : BCR. 2014;16(5):460.. 2014 ;
Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts. " Cell reports. 2013;4(6):1116-30. 2013 ;
Incorporating genomics into breast cancer clinical trials and care. " Clinical cancer research: an official journal. 2013 ;
Li Ding, Amanda G Paulovich, David Fenyö, Matthew J Ellis, Steven A Carr,. " Proteogenomics connects somatic mutations to signalling in breast cancer " 2016 Jun 2; 534 (7605) : 55-62.
Pubmed PMID: 27251275.
Sherri R Davies, Kelly Hunt, Vera J Suman, Jacqueline Snider, Thomas Walsh, Graham A Colditz, Katherine DeSchryver, Richard K Wilson, Elaine R Mardis, Matthew J Ellis. " Aromatase inhibition remodels the clonal architecture of estrogen-receptor-positive breast cancers " 2016 Aug 9; 7
Pubmed PMID: 27502118.